LIVMONIPLIMAB

UNII:	42SH7JCD82
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	LIVMONIPLIMAB
GSRS Full Record:	42SH7JCD82 i

2412004-88-5
ABBV-151
ABBV151
ARGX-115
Immunoglobulin G4 [234-proline], anti-(human protein GARP-transforming growth factor β1 complex) (human monoclonal ABBV-151 γ4-chain), disulfide with human monoclonal ABBV-151 κ-chain, dimer
Immunoglobulin G4-kappa, anti-[Homo sapiens LRRC32 (leucine rich repeat containing 32, transforming growth factor beta activator LRRC32, glycoprotein A repetitions predominant, GARP) / Homo sapiens TGFB1 (transforming growth factor beta1, TGF beta) complex], chimeric and humanized monoclonal antibody; gamma4 heavy chain chimeric (1-452) [VH Vicpac/Homsap (Vicugna pacos IGHV1-1*01 (87.8%) - (IGHD) -IGHJ3*01 (100%)/Homo sapiens IGHV1-46*01 (85.7%) -(IGHD) -IGHJ4*01 (85.7%), CDR-IMGT [8.8.19] (26-33.51-58.97-115)) (1-126)-Homo sapiens IGHG4*01, G4v5 h P10 (CH1 (127-224), hinge 1-12 S10>P (234) (225-236), CH2 (237-346), CH3 (347-451), CHS K2>del (452)) (127-452)], (140-214')-disulfide with kappa light chain humanized (1'-214') [V-KAPPA (Homo sapiens IGKV1-39*01 (85.3%) -IGKJ1*01 (100%), CDRIMGT [6.3.9] (27-32.50-52.89-97)) (1'-107') -Homo sapiens IGKC*01 (100%), Km3 A45.1 (153), V101 (191) (108'-214')]; dimer (232-232'':235-235'')-bisdisulfide, produced in Chinese hamster ovary (CHO) cells, glycoform alfa
LIVMONIPLIMAB [USAN]
Livmoniplimab
Livmoniplimab [WHO-DD]
PR-1762844
livmoniplimab [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

LIVMONIPLIMAB

Synonyms and Mappings

Resources